假体表面类型对乳房翻修术后包膜挛缩复发率的影响
两组各3例(7.5%)复发,差异无统计学意义(p>0.05),提示假体表面类型不影响复发率。
要点
- 毛面与纳米毛面假体在包膜挛缩翻修术后复发率均为7.5%,无统计学差异。
- 两组复发时间分别见于术后7-14个月和9-16个月。
核心结论
- 在包膜挛缩翻修手术中,假体表面类型(毛面或纳米毛面)似乎不影响复发率。
- 需要进一步研究以明确假体表面对包膜挛缩乳房手术长期结局的临床影响。
研究设计与样本
- 所有患者均因初次毛面假体隆乳后Baker III-IV级包膜挛缩行翻修术,手术方式统一为包膜切除-腔隙平面更换-假体置换。
- A组使用毛面假体(Biocell),B组使用纳米毛面假体(SilkSurface)。
主要发现
- A组年龄35(19-65)岁,初次至翻修间隔59(6-209)个月;B组年龄39(26-58)岁,间隔65(7-218)个月。
- A组平均随访25(21-36)个月,B组平均随访24(21-34)个月。
- A组包膜挛缩复发3例(7.5%),发生于术后7、10、14个月;B组复发3例(7.5%),发生于术后9、10、16个月。
- Student t检验显示两种假体表面复发率差异无统计学意义(p>0.05)。
临床怎么用
- 在包膜挛缩翻修术中,毛面与纳米毛面假体的短期复发率相似,假体表面选择可综合考虑其他因素。
- 术后需关注包膜挛缩复发,尤其术后7-16个月区间。
局限性
- 回顾性研究设计,证据等级有限。
- 原文未报告统计学效能或混杂因素控制情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This retrospective comparative study aimed to evaluate the effect of implant surface in two cohorts of consecutive patients who underwent revision surgery following capsular contracture (Baker III-IV) after primary breast augmentation with textured implants. METHODS: All patients underwent the same surgical procedure (capsulectomy - pocket plane change - implant exchange) and the only difference was that two different types of implants were used during the implant exchange: textured(Group A - biocell) or nanotextured(Group B - silksurface). A comparative analysis was performed using the following parameters: patients' demographics, age, the time between the primary breast augmentation and the revision surgery, the surgical and follow-up outcomes; and the incidence, timing, and capsular contracture recurrence. RESULTS: Eighty consecutive females were included, Group A(textured): age of 35(19-65) years and time between primary and secondary surgery of 59(6-209) months; and Group B(nanotextured): age of 39(26-58) years and time between primary and secondary surgery of 65(7-218) months. For both groups, at a mean follow-up of 25(21-36) months for Group A(textured), and at a mean follow-up of 24(21-34) months for Group B(nanotextured); capsular contracture reoccurred in 3 cases (7.5%), at 7, 10, and 14 months in Group A and in 3 cases (7,5%), at 9, 10, and 16 months in Group B, post revision surgery. Students' t-test demonstrated no statistically significant differences between the recurrences of the two implant surfaces (p-value>0.05). CONCLUSION: In capsular contracture revision surgery, the type of implant surface (textured or nanotextured) does not appear to influence recurrence rates. Further studies are required to identify the clinical impact on the implant surface in long-term outcomes of capsular contracture breast surgery.
引用
- Montemurro P, Pellegatta T, Pafitanis G, et al. The effect of implant surface on the recurrence rates of capsular contracture following revision breast surgery: Early results from a single surgeon retrospective comparative study. J Plast Reconstr Aesthet Surg. 2021. PMID: 34210625. doi:10.1016/j.bjps.2021.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。